NEWS
Mini Organs, Major Impact: How Organoids Are Re...
Organoids, miniature, self-organising 3D tissue cultures, are transforming drug development and personalised medicine by offering more physiologically relevant, patient-specific models than traditional 2D cultures and animal testing. This article explores...
Mini Organs, Major Impact: How Organoids Are Re...
Organoids, miniature, self-organising 3D tissue cultures, are transforming drug development and personalised medicine by offering more physiologically relevant, patient-specific models than traditional 2D cultures and animal testing. This article explores...
Grant Writing That Stands Out: How Ambient Cell...
Securing research funding is a competitive process. Review panels look for more than just sound science - they’re also seeking evidence of novel thinking, technical feasibility, and efficient resource use....
Grant Writing That Stands Out: How Ambient Cell...
Securing research funding is a competitive process. Review panels look for more than just sound science - they’re also seeking evidence of novel thinking, technical feasibility, and efficient resource use....
Rise in the use of organoids to replace animal ...
As the industry moves away from animal testing, organoids are emerging as a powerful alternative, offering improved physiological relevance, ethical advantages, and greater efficiency. Atelerix's innovative hydrogel-based preservation technology enables...
Rise in the use of organoids to replace animal ...
As the industry moves away from animal testing, organoids are emerging as a powerful alternative, offering improved physiological relevance, ethical advantages, and greater efficiency. Atelerix's innovative hydrogel-based preservation technology enables...
Transforming mRNA Vaccine Distribution: How Ate...
The rapid advancement of mRNA vaccines has revolutionised medicine, but their reliance on ultracold storage hampers global accessibility, particularly in underserved regions. Atelerix’s CytoStor™ platform offers a game-changing solution by...
Transforming mRNA Vaccine Distribution: How Ate...
The rapid advancement of mRNA vaccines has revolutionised medicine, but their reliance on ultracold storage hampers global accessibility, particularly in underserved regions. Atelerix’s CytoStor™ platform offers a game-changing solution by...
Two Years On: Stem Cell Therapy Brings Sustaine...
At Atelerix, we’re proud to support pioneering work that translates innovative science into real-world patient impact. A recent clinical milestone from our partners at the L V Prasad Eye Institute (LVPEI)...
Two Years On: Stem Cell Therapy Brings Sustaine...
At Atelerix, we’re proud to support pioneering work that translates innovative science into real-world patient impact. A recent clinical milestone from our partners at the L V Prasad Eye Institute (LVPEI)...
Atelerix signs exclusive agreement with MineBio...
Atelerix partners with MineBio to bring cryo-free cell preservation to China, expanding global access to its breakthrough hydrogel technology.The exclusive agreement enables efficient ambient-temperature transport of sensitive biomaterials, supporting growth...
Atelerix signs exclusive agreement with MineBio...
Atelerix partners with MineBio to bring cryo-free cell preservation to China, expanding global access to its breakthrough hydrogel technology.The exclusive agreement enables efficient ambient-temperature transport of sensitive biomaterials, supporting growth...
